Literature DB >> 10656837

Reduction of plasma catecholamines in humans during clinically controlled severe underfeeding.

L Göhler1, T Hahnemann, N Michael, P Oehme, H D Steglich, E Conradi, T Grune, W G Siems.   

Abstract

BACKGROUND: Sympathetic hyperactivity is one factor for alterations encountered in the plurimetabolic syndrome, a cluster of metabolic abnormalities including obesity, hyperlipidemia, sometimes hyperglycaemia, and hypertonia. It was interesting to know if prolonged severe underfeeding (230 kcal/day) leads to decreases in catecholamines in those patients.
METHODS: The plasma concentrations of catecholamines in patients (n = 16) suffering from plurimetabolic syndrome were studied before and during a 16-day period of medically controlled severe underfeeding (230 kcal/day) at rest and in response to exercise.
RESULTS: During the period of underfeeding, mean norepinephrine concentrations decreased at rest from 1.45 to 0. 96 nmol/liter, and in response to exercise, from 6.1 to 3.2 nmol/liter. Epinephrine concentrations decreased from 0.15 to 0.1 nmol/liter and from 0.26 to 0.17 nmol/liter, respectively. A significant decrease in catecholamine concentrations was observed only after 16 days of underfeeding.
CONCLUSIONS: Clinically controlled underfeeding of patients with plurimetabolic syndrome may result in beneficial clinical and biochemical effects. The findings indicate that relatively long periods of underfeeding induce decreases in plasma catecholamine concentrations. Nevertheless, most of the fall in mean values in norepinephrine and also of the fall in blood pressure values occurred by Day 2. From those tendencies and from the significant changes in both parameters at Day 16 of severe underfeeding one could conclude that altered sympathetic nervous system activity could contribute to the fall in blood pressure. Copyright 2000 American Health Foundation and Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10656837     DOI: 10.1006/pmed.1999.0602

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  6 in total

Review 1.  Prolonged fasting as a method of mood enhancement in chronic pain syndromes: a review of clinical evidence and mechanisms.

Authors:  Andreas Michalsen
Journal:  Curr Pain Headache Rep       Date:  2010-04

2.  The relationship between metformin therapy and the fasting plasma lactate in type 2 diabetes: The Fremantle Diabetes Study.

Authors:  T M Davis; D Jackson; W A Davis; D G Bruce; P Chubb
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

3.  Effects of fasting therapy on irritable bowel syndrome.

Authors:  Motoyori Kanazawa; Shin Fukudo
Journal:  Int J Behav Med       Date:  2006

4.  Blood Pressure Changes in 1610 Subjects With and Without Antihypertensive Medication During Long-Term Fasting.

Authors:  Franziska Grundler; Robin Mesnage; Andreas Michalsen; Françoise Wilhelmi de Toledo
Journal:  J Am Heart Assoc       Date:  2020-11-23       Impact factor: 5.501

Review 5.  The Effect of Fasting on Human Metabolism and Psychological Health.

Authors:  Yiren Wang; Ruilin Wu
Journal:  Dis Markers       Date:  2022-01-05       Impact factor: 3.434

6.  Caloric restriction decreases orthostatic tolerance independently from 6° head-down bedrest.

Authors:  John P Florian; Friedhelm J Baisch; Martina Heer; James A Pawelczyk
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.